[1] |
Wanleenuwat P,Suntharampillai N,Iwanowski P.Antibioticinduced epileptic seizures:mechanisms of action and clinical considerations[J].Seizure,2020,81:167-174.
|
[2] |
Zaccara G,Lattanzi S.A review of pharmacokinetic drug interactions between antimicrobial and antiseizure medications in children[J].Epileptic Disord,2021,23(2):229-256.
|
[3] |
Beghi E.The Epidemiology of Epilepsy[J].Neuroepidemiology,2020,54(2):185-191.
|
[4] |
DeGrauw X,Thurman D,Xu L,et al.Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: An analysis of insurance claims data,2004-2014[J].Epilepsy Res,2018,146:41-49.
|
[5] |
Farghaly WM,Abd Elhamed MA,Hassan EM,et al.Prevalence of childhood and adolescence epilepsy in Upper Egypt (desert areas)[J].Egypt J Neurol Psychiatr Neurosurg,2018,54(1):34.
|
[6] |
中华医学会神经外科学分会神经创伤专业组,中华医学会创伤学分会颅脑创伤专业组. 颅脑创伤后癫痫防治中国专家共识[J].中华神经外科杂志,2017,33(7):652-654.
|
[7] |
Cannon JP,Lee TA,Clark NM,et al.The risk of seizures among the carbapenems:a meta-analysis[J].J Antimicrob Chemother,2014,69(8):2043-2055.
|
[8] |
中国抗癫痫协会.临床诊疗指南—癫痫病分册[M].北京:人民卫生出版社,2015:82-89.
|
[9] |
Glauser T,Shinnar S,Gloss D,et al.Evidence-Based Guideline:Treatment of Convulsive Status Epilepticus in Children and Adults:Report of the Guideline Committee of the American Epilepsy Society[J].Epilepsy Curr,2016,16(1):48-61.
|
[10] |
Al-Quteimat O,Laila A.Valproate Interaction With Carbapenems:Review and Recommendations[J].Hosp Pharm,2020,55(3):181-187.
|
[11] |
Chai PYC,Chang CT,Chen YH,et al.Effect of drug interactions between carbapenems and valproate on serum valproate concentration:a systematic review and meta-analysis[J].Expert Opin Drug Saf,2021,20(2):215-223.
|
[12] |
Chen IL,Lee CH,Hsiao SC,et al.Interactions between carbapenems and valproic acid among the patients in the intensive care units[J].J Crit Care,2021,62:151-156.
|
[13] |
Wen ZP,Fan SS,Du C,et al.Drug-drug interaction between valproic acid and meropenem:a retrospective analysis of electronic medical records from neurosurgery inpatients[J].J Clin Pharm Ther,2017,42(2):221-227.
|
[14] |
Miranda Herrero MC,Alcaraz Romero AJ,Escudero Vilaplana V,et al.Pharmacological interaction between valproic acid and carbapenem:what about levels in pediatrics?[J].Eur J Paediatr Neurol,2015,19(2):155-161.
|
[15] |
中国医师协会神经外科医师分会神经重症专家委员会,北京医学会神经外科学分会神经外科危重症学组.神经外科中枢神经系统感染诊治中国专家共识(2021 版)[J].中华神经外科杂志,2021,37(1):2-15.
|
[16] |
Wu CC,Pai TY,Hsiao FY,et al.The Effect of Different Carbapenem Antibiotics (Ertapenem,Imipenem/Cilastatin,and Meropenem)on Serum Valproic Acid Concentrations[J].Ther Drug Monit,2016,38(5):587-592.
|
[17] |
Frantoni AJ,Colmertauer JL,Linder KE,et al.A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use:Are Best Practice Advisories Working?[J].J Pharm Pract,2021,38(5):587-592.
|
[18] |
Payne LE,Gagnon DJ,Rike RR,et al.Cefepime-induced neurotoxicity:a systematic review[J].Crit Care,2017,21(1):276.
|
[19] |
National Institute for Health and Care Excellence.Epilepsies in children,young people and adults [EB/OL].[2022-04-27]https://www.nice.org.uk/guidance/ng217.
|